| 
				   
				
				Certified organic cold pressed FLAXSEED OIL
				52% ALA 
				  
				
				Flaxseed, also known as linseed in some countries, is a good 
				source of dietary fibre, fatty acids and lignans. Its oil is 
				rich in essential fatty acids, Omega-3, 6 and 9, which are 
				important for maintaining optimum health. They have 
				anti-inflammatory, anti-thrombotic, anti-arrhythmic, 
				hypolipidemic and vasodilatory properties. These beneficial 
				effects have been shown in the secondary prevention of coronary 
				heart disease, hypertension, type 2 diabetes, renal disease, 
				rheumatoid arthritis, ulcerative colitis, Crohn’s disease and 
				chronic obstructive pulmonary disease. 
				  
				
				Alpha-linolenic acid (ALA) is an omega-3 fatty acid that is 
				found abundantly in flaxseed oil. It desaturates and elongates 
				in the human body to eicosapentaenoic acid (EPA) and 
				docosahexaenoic acid (DHA) and by itself may have beneficial 
				effects in health and in the control of chronic diseases. 
				  
				
				Short term intervention studies have shown that diets rich in 
				polyunsaturated fats have hypotensive properties. Long term 
				effects of dietary fat on blood pressure have been studied in 
				399 free-living male subjects. The result showed an increase in 
				ALA was associated with a decrease in systolic, diastolic and 
				composite mean arterial blood pressure. Hence dietary 
				manipulation with omega-3 fatty acids may be helpful in the 
				prevention of hypertension. 
				  
				A 
				blind study was done by Singer P et al to determine the effects 
				of essential fatty acids on blood pressure, serum lipids, 
				lipoproteins and the formation of eicosanoid precursors in 
				patients with mild essential hypertension. Forty-four male 
				patients with mild hypertension were allocated to put on diets 
				supplemented with flaxseed oil.  
				  
				
				The subjects ingesting the flaxseed oil-rich diet showed an 
				increase of ALA in serum lipids. In addition to total 
				cholesterol, LDL cholesterol and the LDL/HDL cholesterol ratio, 
				serum triglycerides and lecithin cholesterol acyl transferase 
				activity were significantly depressed. Hence flaxseed oil that 
				is rich in Alpha-linolenic acid has cholesterol-lowering effect. 
				  
				
				This hypocholesterolemic effect has been confirmed by another 
				Canadian research which was studied in eight normolipidic men. 
				The flaxseed oil diet was effective in lowering total and 
				lipoprotein cholesterol and apolipoprotein concentrations in 
				plasma, indicating that dietary ALA was hypocholesterolemic. 
				Therefore flaxseed oil may have beneficial effects for those 
				with high cholesterol and cardiovascular problems such as heart 
				disease. 
				  
				A 
				study on ALA intake reduces the risk of coronary heart disease 
				was reviewed Mozaffarian D. ALA may reduce cardiovascular risk 
				through a variety of biologic mechanisms, including platelet 
				function, inflammation, endothelial cell function, arterial 
				compliance and arrhythmia. Observational studies suggest that 
				ALA intake reduces the incidence of coronary heart disease. 
				Presently the evidence favours recommendations for modest 
				dietary consumption of ALA for the primary and secondary 
				prevention of coronary heart disease. 
				  
				
				Animal studies have shown that diet enriched with omega-3 fatty 
				acid, especially ALA was preventing ventricular fibrillation, 
				the chief mechanism of cardiac death. It was also demonstrated 
				that ALA was the main fatty acid lowering platelet aggregation, 
				an important step in thrombosis, such as non-fatal myocardial 
				infarction and stroke. 
				  
				A 
				study was done to assess the effect of flaxseed oil diet in the 
				rat renal ablation model. Renal ALA and EPA were increased in 
				the flaxseed oil group, and the total omega-3 fatty acids 
				increased twofold to threefold. It was shown that dietary 
				flaxseed oil attenuated the decline in renal function and 
				reduced glomerular injury with favourable effects on blood 
				pressure, plasma lipids and urinary prostaglandins. 
				  
				
				Study of ALA in lupus nephritis patients was performed after it 
				was found beneficial in lupus mouse. Patients were given various 
				amount of flaxseed daily sequentially for four week intervals. 
				Compliance, disease activity, plasma lipids, PAF-induced 
				platelet aggregation, renal function and serum immunology were 
				assessed.  
				  
				
				There was a significant increase of serum ALA which indicated 
				good compliance. Total and LDL cholesterol and blood viscosity 
				were significantly reduced. PAF-induced platelet aggregation was 
				inhibited. It was concluded that flaxseed was well tolerated and 
				conferred benefit in terms of renal function as well as 
				inflammatory and atherogenic mechanisms important in the 
				pathogenesis of lupus nephritis. 
				  
				
				In an Indian perspective, dietary fats are required to meet 
				nutritional needs and prevent the risk of atherosclerosis. Long 
				term high intake of ALA reduces the risk of coronary heart 
				disease. Metabolic studies were conducted in Indian subjects to 
				investigate the effects of using ALA rich oils on plasma lipids, 
				essential fatty acid status and platelet aggregation. The 
				results showed ALA produced anti-atherogenic effects. Regular 
				consumption of plant foods which are good sources of ALA can 
				contribute to improving omega-3 status. 
				  
				
				Omega-3 fatty acids are known to influence inflammatory 
				responses in the body. However its effects on structures such as 
				the intestinal tract were barely understood. A pilot study was 
				conducted into the effects of omega-3 fatty acid deficiency on 
				rat intestinal structure and microbe populations. Wistar rats 
				were randomly divided into two groups, control and experimental. 
				The rats in control group were given feeds containing ALA from 
				age 9-11 weeks until 38-40 weeks.  
				  
				
				The plasma phospholipids of the control group contained greater 
				total omega-3 fatty acid. It was found that increased 
				proportions of haemolytic bacteria in ileum and increased 
				numbers of total bacteria and lactic acid bacteria in the caecum 
				of the experimental group. It was established that omega-3 fatty 
				acid deficiency does affect rat intestinal structure and microbe 
				populations. Results suggest that a deficiency of omega-3 fatty 
				acid can lead to increased cell proliferation, inflammation and 
				microbe overgrowth in the normal intestinal tract. 
				  
				
				Omega-3 fatty acids have been extensively studied in the brain. 
				ALA deficiency was demonstrated to alter the structure and 
				function of membranes by altering the course of brain 
				development, perturbing the composition and physiochemical 
				properties of brain cell membranes, neurones, oligodendrosytes 
				and astrocytes. This leads to physiochemical modifications, 
				induces biochemical and physiological perturbations and results 
				in neurosensory and behavioural upset.  
				  
				
				Recent results have shown that dietary ALA deficiency induces 
				marked abnormalities in certain cerebral structures, as the 
				frontal cortex and pituitary gland are severely affected. And 
				ALA deficiency also decreases the perception of pleasures, by 
				slightly altering the efficacy of sensory organs and by 
				affecting certain cerebral structures. 
				  
				A 
				French study investigated the relation between the dietary ALA 
				deficiency and a simple form of learning, habituation, in mice. 
				The results suggest that habituation occurs more slowly in mice 
				fed a diet deficient in ALA. Hence, it is important to 
				supplement ALA during the period of learning especially in 
				children. 
				  
				
				Animal studies report a possible protective role for ALA against 
				breast cancer. Fristsche KL and Johnston PV studied the effect 
				of dietary omega-3 fatty acid on mammary tumour growth and 
				metastasis. Weanling female mice were fed flaxseed oil diet for 
				3-8 weeks prior to receiving injections of mammary tumour cell 
				types. Tumour growth was assessed by monitoring mean tumour 
				diameter and weight upon removal.  
				  
				
				Feeding flaxseed oil reduced the growth of mammary tumours, 
				enhanced incorporation of omega-3 fatty acids into tumours and 
				reduced tumour prostaglandin E production. The result suggested 
				an inhibitory effect of dietary linolenic acid on mammary tumour 
				growth and metastasis.  
				  
				
				Another study determined whether supplementation with flaxseed 
				oil beginning 13 weeks after carcinogen administration would 
				reduce the size of established mammary tumours and appearance of 
				new tumours in rats. Flaxseed oil is found more effective at the 
				stage when tumours have already been established. 
				  
				A 
				Norway research found out that deficiency of ALA has been 
				observed in patients with skin problems. The clinical symptoms 
				include hemorrhagic dermatitis, hemorrhagic folliculitis, skin 
				atrophy and scaly dermatitis. Supplementation of Omega-3 fatty 
				acid normalized these symptoms. Hence, this essential fatty acid 
				has an important role in the maintenance of the skin. 
				  
				
				In vitro experiments using cultured murine melanoma cells showed 
				that melanin production was inhibited most effectively by ALA, 
				followed by linoleic acid and oleic acid, which are fatty acids 
				found in flaxseed oil.  
				  
				
				ALA was studied to evaluate its effects on ultraviolet-induced 
				hyperpigmentation of the skin of brownish guinea pigs. The 
				result showed ALA accelerated the turnover of the stratum 
				corneum, which plays an important role in the removal of melanin 
				pigment from the epidermis. Therefore, flaxseed oil containing 
				ALA has pigment-lightening effects.  
				  
				A 
				Japanese research examined the effect of ALA on histamine 
				release in basophilic leukaemia (RBL-2H3) cells. It was found 
				that the content of histamine in ALA-treated cells was 
				remarkably lower than that of untreated cells. Accordingly, the 
				net and percentage of histamine release stimulated by antigen 
				was also markedly decreased in the ALA-treated cells. Results 
				suggest that the anti-allergic effect of ALA may be caused by 
				the decrease in histamine content or by inhibition of the 
				release of chemical mediator resulting from the changes in the 
				fatty acid composition. Hence this essential omega-3 fatty acid 
				may be beneficial for allergy reactions such as hayfever, hives, 
				asthma and sinusitis. 
				  
				
				The association between intake of omega-3 fatty acid and risk of 
				community-acquired pneumonia (lung infection) was examined in 
				38,378 US male health professionals aged 44-79 years. Their 
				medical and lifestyle information were updated through 
				questionnaires and blinded medical record review of chest 
				radiographs were used to determine pneumonia. 
				  
				
				During 10 years of follow-up, there were 441 new cases of 
				nonfatal pneumonia. Pneumonia risk was found to be reduced by 
				31% for every 1 gram/day increase in ALA intake. It was 
				concluded that higher intakes of ALA may be reduce the risk of 
				pneumonia. 
				  
				
				Maternal essential fatty acid status declines during pregnancy. 
				The effect of ALA supplementation during pregnancy on maternal 
				and neonatal polyunsaturated fatty acid status and pregnancy 
				outcome was studied in Netherland. Pregnant women were 
				supplemented with ALA and Linoleic Acid (LA), the ultimate 
				precursors of DHA and AA, from week 14 of gestation until 
				delivery.  
				  
				
				ALA and LA supplementation significantly increased EPA and DHA 
				concentrations and lowered neonatal AA status. It is suggested 
				that functional DHA status improves with ALA and LA 
				supplementation. Therefore supplementing flaxseed oil may be 
				beneficial for improving DHA status during pregnancy. 
				  
				
				In summary, flaxseed oil is a rich source of ALA, omega-3 fatty 
				acid that is readily absorbed from the intestine into the 
				bloodstream. It has hypotensive, anti-atherogenic, 
				hypocholesterolemic, anti-inflammatory, anti-allergic and 
				pigment-lightening properties. A deficiency in ALA may induce 
				problems in intestines, brain, nerve and skin. ALA may improve 
				DHA status during pregnancy and play an important role on 
				learning. It also has been shown to reduce the growth of tumours 
				and the risk of coronary heart disease and pneumonia. 
				 
				
				  
				 |